Cell and Gene Therapy Market: Set to Explode and Reach US$ 43.0 Billion by 2028

IMARC Group, a leading market research company, has recently releases report titled “Cell and Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cell and gene therapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the cell and gene therapy market?

The global cell and gene therapy market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 43.0 Billion by 2028, exhibiting a growth rate (CAGR) of 17.4% during 2023-2028.

What is cell and gene therapy?

Cell and gene therapy represents a pioneering approach to medical treatment that harnesses the potential of cellular and genetic interventions to address various health conditions. Differing from traditional medical approaches, cell and gene therapy employs advanced technologies to modify or replace faulty genes or cells within a patient's body. This method holds promise in treating a wide spectrum of diseases, from genetic disorders to certain types of cancer. Healthcare professionals and research institutions are actively utilizing these innovative therapies to provide tailored medical solutions, including personalized gene editing and cell-based regenerative treatments. The versatility and precision of cell and gene therapy offer a transformative avenue for medical advancements, presenting new possibilities for patients and medical practitioners alike.

Request for a sample report or buy full report: https://www.imarcgroup.com/cell-gene-therapy-market/requestsample

What are the growth prospects and trends in the cell and gene therapy industry?

The escalating demand for novel medical interventions, coupled with significant scientific progress, is driving the growth of the cell and gene therapy field. Additionally, healthcare organizations and research establishments are increasingly embracing cutting-edge technologies in this realm to elevate patient care and advance medical boundaries. Amid these developments, cell and gene therapy emerge as dynamic and transformative segments within the broader healthcare landscape, catalyzing the evolution of medical treatments. Moreover, adherence to rigorous regulatory frameworks and a steadfast commitment to ensuring patient safety and ethical considerations play a pivotal role in shaping the trajectory of the cell and gene therapy sector. The facilitation and promotion of these therapies are integral to addressing the evolving healthcare needs of individuals, thereby fostering the sector's expansion. Furthermore, ongoing research and development activities play a fundamental role in advancing these therapies, unlocking new avenues for addressing previously untreatable conditions.

Who are the key players operating in the industry?

The report covers the major market players including:

Amgen Inc.
Biogen
Bluebird bio, Inc.
Bristol-Myers Squibb
Gilead Science
Kolon TissueGene Inc.
Orchard Therapeutics plc.
Pfizer Inc
Renova Therapeutics
Spark Therapeutics, Inc.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Therapy Type:

Cell Therapy

Stem Cell

Pluripotent Stem Cell
Cancer Stem Cell
Adult Stem Cell

Non-Stem Cell

T Cells
Natural Killer
Others

Gene Therapy

Breakup by Indication:

Cardiovascular Disease
Oncology Disorder
Genetic Disorder
Infectious Disease
Neurological Disorder
Others

Breakup by Delivery Mode:

In-Vivo
Ex-Vivo

Breakup by End User:

Hospitals
Cancer Care Centers
Pharmaceutical Biotechnology Companies
Others

Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=reportid=6964flag=C\

Key Highlights of the Report:

Market Performance (2017-2022)
Market Outlook (2023-2028)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/